Antares acquires IP for drug delivery technology
Advertisement
As part of the agreement, Antares Pharma has acquired intellectual property including multiple patents for prefilled cartridge technology particularly suited to jet injection. This includes reusable injector system technology adapted for use with prefilled cartridges and composite cartridge technology that can overcome the challenges inherent to the high pressures involved in jet injection. The patented technology also takes into account the pharmaceutical requirements for the storage of the injectable drugs.
Under the terms of the agreement, Endoscoptic and Antares Pharma will initiate collaborations to bring projects to market. The agreement supports the continued development of needle-free syringe cartridges as the primary containers for pharmaceutical products by combining Endoscoptic's technology with Antares Pharma's experience and expertise in designing and manufacturing needle-free injection systems.
Dr. Roger Harrison, CEO of Antares Pharma, said, "The Endoscoptic technology has an excellent synergy with ongoing development work at Antares Pharma, and we anticipate that our ongoing collaboration will further speed the development of these new injector platforms."